{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:22:53Z","timestamp":1773746573995,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ejps.2020.105402","type":"journal-article","created":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T01:52:48Z","timestamp":1590889968000},"page":"105402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Pyrazinamide alleviates rifampin-induced steatohepatitis in mice by regulating the activities of cholesterol-activated 7\u03b1-hydroxylase and lipoprotein lipase"],"prefix":"10.1016","volume":"151","author":[{"given":"Wanying","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jufang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangyin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhao","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7373-6356","authenticated-orcid":false,"given":"Zhenghuai","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejps.2020.105402_bib0001","first-page":"192","article-title":"Antituberculosis drug-induced hepatotoxicity: concise up-to-date review","volume":"23","author":"Alma","year":"2010","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"13","key":"10.1016\/j.ejps.2020.105402_bib0002","first-page":"710","article-title":"The clinical characteristics of anti-tuberculosis drug induced liver injury in 2457 hospitalized patients with tuberculosis in China","volume":"7","author":"An","year":"2013","journal-title":"Afr. J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2020.105402_bib0003","doi-asserted-by":"crossref","unstructured":"Bak SU, Kim S, Hwang HJ, et\u00a0al. Heme oxygenase-1 (HO-1)\/carbon monoxide (CO) axis suppresses RANKL-induced osteoclastic differentiation by inhibiting redox-sensitive NF-\u03baB activation. 2017;50(2):103-108.","DOI":"10.5483\/BMBRep.2017.50.2.220"},{"key":"10.1016\/j.ejps.2020.105402_bib0004","first-page":"44","article-title":"Risk factors of isoniazid-induced hepatotoxicity in Tunisian tuberculosis patients","volume":"29","author":"Ben","year":"2016","journal-title":"Pharmacogenomics J."},{"issue":"1","key":"10.1016\/j.ejps.2020.105402_bib0005","first-page":"37","article-title":"Liver transplantation for drug-induced acute liver failure","volume":"21","author":"Biolato","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.ejps.2020.105402_bib0006","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/endo.137.1.8536636","article-title":"Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat","volume":"137","author":"Braissant","year":"1996","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.ejps.2020.105402_bib0007","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm3312","article-title":"Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR","volume":"13","author":"Calkin","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.ejps.2020.105402_bib0008","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/mnfr.201100799","article-title":"The effect of taurine on cholesterol metabolism","volume":"56","author":"Chen","year":"2012","journal-title":"Mol. Nutr. Food Res."},{"issue":"3","key":"10.1016\/j.ejps.2020.105402_bib0009","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1073\/pnas.0336235100","article-title":"Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance","volume":"100","author":"Dussault","year":"2003","journal-title":"PNAS"},{"key":"10.1016\/j.ejps.2020.105402_bib0010","article-title":"Conjugated bile acids activate the sphingosine-1\u2010;phosphate receptor 2 in primary rodent hepatocytes","volume":"55","author":"Elaine","year":"2012","journal-title":"Hepatology"},{"issue":"s2","key":"10.1016\/j.ejps.2020.105402_bib0011","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1463-1326.2010.01275.x","article-title":"Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c","volume":"12","author":"Ferr\u00e9","year":"2010","journal-title":"Diabetes Obes. Metab."},{"issue":"4","key":"10.1016\/j.ejps.2020.105402_bib0012","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1074\/jbc.M209525200","article-title":"The farnesoid X-receptor is an essential regulator of cholesterol homeostasis","volume":"278","author":"Gilles","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ejps.2020.105402_bib0013","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.cmet.2014.01.017","article-title":"The GPIHBP1-LPL complex is responsible for the margination of triglyceride-rich lipoproteins in capillaries","volume":"19","author":"Goulbourne","year":"2014","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.ejps.2020.105402_bib0014","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/toxsci\/kfw098","article-title":"Pyrazinamide induced rat cholestatic liver injury through inhibition of fxr regulatory effect on bile acid synthesis and transport","volume":"152","author":"Guo","year":"2016","journal-title":"Toxicol. Sci."},{"issue":"18","key":"10.1016\/j.ejps.2020.105402_bib0015","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.2169\/internalmedicine.54.5533","article-title":"Currently used low-dose pyrazinamide does not increase liver-injury in the first two months of tuberculosis treatment","volume":"54","author":"Horita","year":"2015","journal-title":"Intern. Med."},{"issue":"11","key":"10.1016\/j.ejps.2020.105402_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165787","article-title":"Rifampicin-induced hepatic lipid accumulation: association with up-regulation of peroxisome proliferator-activated receptor \u03b3 in mouse liver","volume":"11","author":"Huang","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ejps.2020.105402_bib0017","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.ejps.2020.105402_bib0018","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijmyco.2015.10.001","article-title":"Antituberculosis drugs and hepatotoxicity among hospitalized patients in Jos, Nigeria","volume":"5","author":"Isa","year":"2016","journal-title":"Int. J. Mycobacteriol."},{"issue":"1-2","key":"10.1016\/j.ejps.2020.105402_bib0019","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0378-1119(00)00518-7","article-title":"Regulation of cholesterol 7??-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXR??)","volume":"262","author":"John","year":"2001","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.ejps.2020.105402_bib0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1210\/mend.14.1.0409","article-title":"The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution","volume":"14","author":"Jones","year":"2000","journal-title":"Mol. Endocrinol."},{"issue":"1","key":"10.1016\/j.ejps.2020.105402_bib0021","first-page":"13","article-title":"Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis","volume":"83","author":"Kaneko","year":"2008","journal-title":"Kekkaku"},{"key":"10.1016\/j.ejps.2020.105402_bib0022","doi-asserted-by":"crossref","unstructured":"Kimihiko M.[Novel mechanism for hepatic lipid accumulation: a physiological role for hepatic PPAR\u03b3-fsp27 signal]. 2012;132(7):823-829.","DOI":"10.1248\/yakushi.132.823"},{"issue":"4","key":"10.1016\/j.ejps.2020.105402_bib0023","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF00558302","article-title":"Pharmacokinetics of pyrazinamide and its metabolites in healthy subjects","volume":"36","author":"Lacroix","year":"1989","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2020.105402_bib0024","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbalip.2017.08.007","article-title":"Cyp7a1 is continuously increased with disrupted Fxr-mediated feedback inhibition in hypercholesterolemic TALLYHO\/Jng mice","volume":"1863","author":"Lee","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.ejps.2020.105402_bib0025","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1378\/chest.123.1.102","article-title":"Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis: improved completion rates but more hepatotoxicity","volume":"123","author":"Lee","year":"2003","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ejps.2020.105402_bib0026","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1152\/ajpgi.00258.2004","article-title":"Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription","volume":"288","author":"Li","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver. Physiol."},{"key":"10.1016\/j.ejps.2020.105402_bib0027","doi-asserted-by":"crossref","first-page":"e20958","DOI":"10.7554\/eLife.20958","article-title":"The angiopoietin-like protein ANGPTL4 catalyzes unfolding of the hydrolase domain in lipoprotein lipase and the endothelial membrane protein GPIHBP1 counteracts this unfolding","volume":"5","author":"Mysling","year":"2016","journal-title":"eLife"},{"issue":"20","key":"10.1016\/j.ejps.2020.105402_bib0028","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1002\/cmdc.201600305","article-title":"Development of Tetrachlorophthalimides as liver X receptor \u03b2 (LXR\u03b2)-selective agonists","volume":"11","author":"Nomura","year":"2016","journal-title":"Chem. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejps.2020.105402_bib0029","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0092-8674(00)81432-4","article-title":"Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha","volume":"93","author":"Peet","year":"1998","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ejps.2020.105402_bib0030","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2010.12.004","article-title":"The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation","volume":"54","author":"Pols","year":"2013","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.ejps.2020.105402_bib0031","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jceh.2012.12.001","article-title":"Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management","volume":"3","author":"Ramappa","year":"2013","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"3","key":"10.1016\/j.ejps.2020.105402_bib0032","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000450917","article-title":"Role of the g protein-coupled bile acid receptor TGR5 in liver damage","volume":"35","author":"Reich","year":"2017","journal-title":"Dig. Dis."},{"issue":"22","key":"10.1016\/j.ejps.2020.105402_bib0033","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1101\/gad.844900","article-title":"Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta","volume":"14","author":"Repa","year":"2000","journal-title":"Genes. Dev."},{"issue":"2","key":"10.1016\/j.ejps.2020.105402_bib0034","doi-asserted-by":"crossref","first-page":"188","DOI":"10.5588\/ijtld.13.0128","article-title":"Correlation of plasma anti-tuberculosis drug levels with subsequent development of hepatotoxicity","volume":"18","author":"Satyaraddi","year":"2014","journal-title":"Int. J. Tuberc. Lung Dis. Off. J. Int. Union Against Tuberc. Lung Dis."},{"key":"10.1016\/j.ejps.2020.105402_bib0035","doi-asserted-by":"crossref","unstructured":"Schaap FG, Trauner M, Jansen PLM. Bile acid receptors as targets for drug development. Nat. Rev. Gastroenterol. Hepatol.11(1):55-67.","DOI":"10.1038\/nrgastro.2013.151"},{"issue":"22","key":"10.1016\/j.ejps.2020.105402_bib0036","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1101\/gad.850400","article-title":"Role of LXRs in control of lipogenesis","volume":"14","author":"Schultz","year":"2000","journal-title":"Genes Dev."},{"issue":"8402","key":"10.1016\/j.ejps.2020.105402_bib0037","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(84)90764-5","article-title":"Aetiology of pneumonia in children in goroka hospital, Papua new guinea","volume":"324","author":"Shann","year":"1984","journal-title":"Lancet"},{"issue":"43","key":"10.1016\/j.ejps.2020.105402_bib0038","doi-asserted-by":"crossref","first-page":"29836","DOI":"10.1074\/jbc.M114.582783","article-title":"Protein\/protein interactions in the mammalian heme degradation pathway: heme oxygenase-2, cytochrome P450 reductase, and biliverdin reductase","volume":"289","author":"Spencer","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejps.2020.105402_bib0039","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/hep.24681","article-title":"Conjugated bile acids activate the sphingosine-1\u2010phosphate receptor 2 in primary rodent hepatocytes","volume":"55","author":"Studer","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.ejps.2020.105402_bib0040","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Tiangang","year":"2014","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.ejps.2020.105402_bib0041","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/hep.23721","article-title":"Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice","volume":"52","author":"Tiangang","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.ejps.2020.105402_bib0042","first-page":"534","article-title":"Severe hepatotoxicity due to anti-tuberculosis drugs in Spain","volume":"9","author":"Tost","year":"2005","journal-title":"Int. J. Tubelc. Lung Dis."},{"issue":"3","key":"10.1016\/j.ejps.2020.105402_bib0043","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000220356","article-title":"Comparison of the antituberculous activity of morphazinamide and pyrazinamide on chronic experimental tuberculosis. i. the antimycobacterial efficacy made in vitro and in vivo","volume":"9","author":"Trnka","year":"1964","journal-title":"Chemotherapy"},{"issue":"2","key":"10.1016\/j.ejps.2020.105402_bib0044","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.23708","article-title":"Glycosylation of fibroblast growth factor receptor 4 is a key regulator of fibroblast growth factor 19-mediated down-regulation of cytochrome P450 7A1","volume":"52","author":"Vassilis","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ejps.2020.105402_bib0045","unstructured":"WHO. Global tuberculosis report2019. https:\/\/www.who.int\/tb\/publications\/global_report\/en\/. Accessed."},{"issue":"04","key":"10.1016\/j.ejps.2020.105402_bib0046","article-title":"Studies on characteristics of liver injury model induced by rifampicin and isoniazid in mice","volume":"35","author":"XIANG","year":"2019","journal-title":"Chin. Pharmacol. Bull."},{"issue":"7","key":"10.1016\/j.ejps.2020.105402_bib0047","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1073\/pnas.0438010100","article-title":"Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor","volume":"100","author":"Xie","year":"2003","journal-title":"PNAS"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720301913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720301913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:54:11Z","timestamp":1760529251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098720301913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":47,"alternative-id":["S0928098720301913"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105402","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyrazinamide alleviates rifampin-induced steatohepatitis in mice by regulating the activities of cholesterol-activated 7\u03b1-hydroxylase and lipoprotein lipase","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105402"}}